Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 1,933,177 |
|
|||||
| News | (4) | ||||||
| Day High | 4.83 | Low High |
|||||
| Day Low | 4.645 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| MannKind Corporation | MNKD | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.04 | 0.84% | 4.78 | 16:40:41 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 4.68 | 4.645 | 4.83 | 4.82 | 4.74 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 10,445 | 1,933,177 | US$ 4.75 | US$ 9,175,000 | - | 3.17 - 5.75 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 17:08:09 | 2 | US$ 4.809 | USD |
MannKind Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.31B | 270.42M | - | 198.96M | -11.94M | -0.04 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
MannKind News
| Date | Time | Source | News Article |
|---|---|---|---|
| 5/21/2024 | 20:00 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 5/21/2024 | 20:00 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 5/21/2024 | 20:00 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 5/21/2024 | 20:00 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 5/21/2024 | 15:09 | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities |
| 5/21/2024 | 15:07 | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities |
| 5/17/2024 | 20:36 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 5/17/2024 | 20:35 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MNKD Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.59 | 4.83 | 4.40 | 4.61 | 2,229,688 | 0.19 | 4.14% |
| 1 Month | 4.15 | 4.83 | 4.11 | 4.40 | 2,059,730 | 0.63 | 15.18% |
| 3 Months | 3.90 | 5.40 | 3.8637 | 4.51 | 3,012,949 | 0.88 | 22.56% |
| 6 Months | 3.71 | 5.40 | 3.17 | 4.06 | 2,765,903 | 1.07 | 28.84% |
| 1 Year | 4.65 | 5.75 | 3.17 | 4.21 | 2,733,071 | 0.13 | 2.80% |
| 3 Years | 4.24 | 5.75 | 2.49 | 4.14 | 3,401,100 | 0.54 | 12.74% |
| 5 Years | 1.32 | 6.25 | 0.80 | 3.52 | 3,305,191 | 3.46 | 262.12% |
MannKind Description
| MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler. |
